|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2007-1-22
|
|
pubmed:abstractText |
Implantable cardioverter defibrillators (ICDs) reduce mortality among appropriately selected patients who have had or are at risk for life-threatening ventricular arrhythmia. Right ventricular apical (RVA) pacing has been implicated in worsening heart failure and death. The optimal pacemaker mode for bradycardia support while minimizing unnecessary and potentially harmful RVA pacing has not been determined.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1540-8167
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1295-8
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:17081208-Canada,
pubmed-meshheading:17081208-Cardiac Pacing, Artificial,
pubmed-meshheading:17081208-Defibrillators, Implantable,
pubmed-meshheading:17081208-Electric Countershock,
pubmed-meshheading:17081208-Europe,
pubmed-meshheading:17081208-Follow-Up Studies,
pubmed-meshheading:17081208-Heart Failure,
pubmed-meshheading:17081208-Humans,
pubmed-meshheading:17081208-Israel,
pubmed-meshheading:17081208-Multicenter Studies as Topic,
pubmed-meshheading:17081208-Prognosis,
pubmed-meshheading:17081208-Randomized Controlled Trials as Topic,
pubmed-meshheading:17081208-Research Design,
pubmed-meshheading:17081208-Risk Assessment,
pubmed-meshheading:17081208-Risk Factors,
pubmed-meshheading:17081208-United States
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
|
|
pubmed:affiliation |
Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. mosweeney@partners.org
|
|
pubmed:publicationType |
Journal Article
|
